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Abstract:  The objective of this study was to evaluate inter-individual variability in 
absorbed and internal doses after multi-route exposure to drinking water contaminants 
(DWC) in addition to the corresponding variability in equivalent volumes of ingested 
water, expressed as liter-equivalents (LEQ). A multi-route PBPK model described 
previously was used for computing the internal dose metrics in adults, neonates, children, 
the elderly and pregnant women following a multi-route exposure scenario to chloroform 
and to tri- and tetra-chloroethylene (TCE and PERC). This scenario included water 
ingestion as well as inhalation and dermal contact during a 30-min bathroom exposure. 
Monte Carlo simulations were performed and distributions of internal dose metrics were 
obtained. The ratio of each of the dose metrics for inhalation, dermal and multi-route 
exposures to the corresponding dose metrics for the ingestion of drinking water alone 
allowed computation of LEQ values. Mean BW-adjusted LEQ values based on absorbed 
doses were greater in neonates regardless of the contaminant considered (0.129–0.134 L/kg 
BW), but higher absolute LEQ values were obtained in average adults (3.6–4.1 L), elderly 
(3.7–4.2 L) and PW (4.1–5.6 L). LEQ values based on the parent compound’s AUC were 
much greater than based on the absorbed dose, while the opposite was true based on 
metabolite-based dose metrics for chloroform and TCE, but not PERC. The consideration 
OPEN ACCESSInt. J. Environ. Res. Public Health 2010, 7          
 
 
4003
of the 95th percentile values of BW-adjusted LEQ did not significantly change the results 
suggesting a generally low intra-subpopulation variability during multi-route exposure. 
Overall, this study pointed out the dependency of the LEQ on the dose metrics, with 
consideration of both the subpopulation and DWC. 
Keywords:  drinking water contaminants; inter-individual variability; liter-equivalents; 
multi-route exposure; physiologically-based pharmacokinetic modeling 
 
1. Introduction  
When establishing drinking water guidelines (DWG, in mg/L) of chemical contaminants on the 
basis of non-carcinogenic effects, regulatory agencies account for the average daily ingestion rate of 
water (IRW, L/day) by an adult [1]: 
IRW
  RCS   BW      TRV
  DWG 
 

 
(1) 
where TRV is the toxicological reference value (in mg/kg BW_day), BW is the body weight of an 
average adult (i.e., 70 kg), and RCS is the relative source contribution (20% by default) of drinking 
water to total exposure. For several drinking water contaminants (DWC) that are volatile and/or 
lipophilic, exposure can also result from the inhalation of vapors emitted from water as well as from 
the dermal contact during water usage for hygiene and domestic purposes. Such "multi-route 
exposure" has been well documented for trichloroethylene (TCE) and chloroform based on 
experimental data as the absorbed dose resulting from the inhalation of vapors and the dermal 
exposure to water could actually equal or even exceed the absorbed dose resulting from the ingestion 
of drinking water [2-7]. These results were also confirmed by dose estimates [8] and physiologically-
based pharmacokinetic (PBPK) modeling [9]. Deterministic PBPK modeling has also been used to 
evaluate the contribution of inhalation and dermal exposure to internal doses and/or cancer risk of 
chloroform [10], tetrachloroethylene (PERC, [11]) and methyl-t-butyl-ether (MTBE, [12]). 
The notion of “liter equivalent” (LEQ) has been defined as the amount of water that needs to be 
ingested to absorb an equivalent dose of DWC by other routes of exposure (i.e., inhalation, dermal). 
As an example, an adult's inhalation exposure to chloroform during an eight-minute shower has been 
estimated to generate an absorbed dose that corresponds to 17% of the total dose absorbed, which is 
equivalent to ingesting 0.46 L of water [8]. In addition, a ten-minute shower generated a LEQ of  
0.50–0.57 L [6,9]. Dermal exposure has been estimated to contribute to 19 and 31% of the total 
absorbed dose in adults during a 10- and 30-min shower, respectively [9]. As a result, Haddad et al. [9] 
determined that multi-route exposure to chloroform, including ingestion, inhalation and dermal contact 
for 10- and 30-min showers resulted in absorbed doses equivalent to the doses resulting from ingestion 
of 2.65 and 4.65 L in a 70 kg adult. For TCE, values of 2.51 and 4.54 LEQ were respectively reported 
for 10- and 30-min showers. 
LEQ values of 7.2 and 4 have been used by CalEPA [13] and Health Canada [14], respectively, in 
the establishment of drinking water guidelines for TCE. Also, a value of 4.11 LEQ was determined for Int. J. Environ. Res. Public Health 2010, 7          
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trihalomethanes on the basis of data for chloroform [15]. For PERC, Health Canada has determined 
that the contribution of the dermal route is equivalent to that of the oral ingestion [16]. Such values 
were based on estimates of the absorbed doses in average adults. Haddad et al. [9] showed, however, 
that the LEQ values differ significantly when based on internal dose metrics (DM) such as the area 
under the blood concentration versus time curve (AUC) or the amount metabolized (Amet), instead of 
the absorbed dose. This issue appears important when considering the mode of action of a chemical 
underlying the toxicological reference values or health guidelines [17].  
In addition, multi-route exposure and corresponding calculations of LEQ in subpopulations other 
than average adults have barely been examined. In this regard, Krishnan and Carrier [18] evaluated the 
contribution of inhalation and dermal exposure in representative children aged 6, 10 and 14 years, as 
well as representative adults, by a deterministic PBPK modeling approach. For a 30-min bath, the LEQ 
values for the sum of inhalation and dermal exposure in these subgroups were 1.45, 1.79, 2.14, and 
2.61 LEQ, respectively, for chloroform. For TCE, LEQ values were also determined for a 10-year old 
child (1.9 LEQ), a 14-year old adolescent (2.25 LEQ) and a 70 kg adult (2.41 LEQ). Other 
subpopulations like pregnant women (PW) or the elderly have not been subjected to such evaluation, 
even though it appears logical that in the particular case of PW, their high inhalation rates and dermal 
surface area [19,20] could result in greater BW-adjusted intake of DWC via inhalation or   
dermal contact.  
Therefore, since the inter-individual variability in absorbed and internal doses during multi-route 
exposure to DWCs has not been evaluated to-date, the objectives of this study were: to evaluate the 
inter-individual variability in absorbed and internal doses during multi-route exposure to DWC; and to 
estimate the corresponding variability in LEQ values.  
2. Methods 
The overall method involved using a physiologically-based pharmacokinetic (PBPK) model to 
compute distributions of LEQ values on the basis of probabilistic distributions of internal DM 
following a multi-route exposure scenario to known DWCs, namely chloroform and tri- and   
tetra-chloroethylene (TCE and PERC). Such distributions were obtained in various subpopulations 
(adults, neonates, children, elderly and pregnant women) by means of Monte Carlo (MC) simulations 
that account for the variability in the input parameters of the PBPK model.  
2.1. PBPK Model Structure and Parameters for Specific Subpopulations 
The previously published and validated PBPK model [21] for chloroform, TCE and PERC written 
in Microsoft Excel
 (Microsoft Corporation, Seattle, WA) as per Haddad et al. [22] was used for this 
study. Briefly, this model consists of six basic compartments (liver, fat, skin, kidneys, richly perfused 
tissues and rest of the body), with a seventh compartment (foeto-placental unit) being added for 
pregnant women. As a useful feature with regard to the study of interindividual variability in internal 
dose metrics, the model ensures that physiological parameters are correlated for a given body 
weight/height, age and gender, while authorizing age-specific variations in the relationships between 
the physiological parameters and their determinants. To do so, this model framework includes 
mathematical equations that allow the calculation of physiological parameters as a function of four Int. J. Environ. Res. Public Health 2010, 7          
 
 
4005
determinants, namely body weight, height, age, and gender. Additionally, a “variability term” based on 
data of the literature [23-26] is included as a multiplier of the results of selected physiological 
parameter values calculated with these equations in order to account for the variability in the 
physiology of two persons of identical age, gender and body mass index. Finally, first order 
metabolism is considered to occur mainly in the liver, with a minor contribution of kidneys in the case 
of chloroform and PERC. In computing the metabolism, the model allows the use of catalytic turnover 
of CYP2E1 (in pmol/mg of microsomal protein, MSP), the isozyme involved in the metabolism of the 
contaminants investigated and for which data on inter-individual variability are available [27,28].  
Table 1 shows the statistics, explained in detail in previous work [21], describing the physiological 
determinants of the investigated subpopulations. These data were based on the P
3M database (The 
Lifeline Group Inc, Annandale, VA) [29], as well as the literature [20,23-28,30-34]. Apart from adults 
(18–64 years), four presumably sensitive subpopulations were chosen for this study: neonates   
(birth–30 day), children (1–3 years), elderly (65–90 years) and pregnant women (PW; 38th week  
of gestation).  
Table 1. Probabilistic and deterministic descriptors used to define subpopulation-specific 
parameters in the PBPK models 
a). 
Subpopulation 
Median age (range)
Parameter  
Adults 
41 (18–64) 
(a)
Neonates 
14 d (0–30 d) 
(a)
Children
 (1–3) 
(a)
Elderly 
78 (65–90) 
(a) 
Pregnant women
29 (15–44) 
(a) 
PROBABILISTIC VARIABLES 
(b) 
Body weight  
(kg, mean ± SD, range): 
 
76 ± 17,  
37–152 
(c) 
 
4 ± 1,  
2–7 
 
13 ± 2, 
7–32 
(c) 
 
72 ± 16,  
33–155 
(c) 
 
82 ± 18,  
48–166 
Body height  
(cm, mean ± SD, range): 
167 ± 10, 
144–198 
(c) 
46 ± 16,  
35–80 
87 ± 6, 
70–106 
(c)
164 ± 10,  
138–190 
(c) 
161 ± 7,  
132–182 
(c) 
CYP2E1 concentration  
(pmol/mg MSP, mean ± SD): 
49 ± 2,  
11–130
 (d) 
18 ± 14,  
1–56 
42 ± 18, 
18–74 
(e) (e) 
DETERMINISTIC VARIABLES 
Glomerular filtration rate 
(mL/min_1.73 m
2) 
 
116.0 
 
40.2 
 
127.0 
 
92.4 
 
181.0 
Drinking water ingestion rate  
(mL/day-kg BW)  
19.9 52.4  46.8  21.8  21 
REFERENCES  [28,30,33]  [27,32,33]   [27,33] [28,30,33] [28,30,31,34] 
Notes: (a) See Valcke and Krishnan [21] for details. (b) Log-normally distributed. (c) P
3M database (see [29]). 
(d) Geometric mean ± geometric standard deviation. (e) Same as for adults. Abbreviations: BW = body weight; 
MSP = microsomal protein; SD = standard deviation. 
 
2.2. Exposure Scenarios and Dose Metrics Computed 
For each subpopulation, a multi-route exposure scenario to each drinking water contaminant was 
simulated. Chemical-specific data taken from the literature are indicated in Table 2.  Int. J. Environ. Res. Public Health 2010, 7          
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Table 2. Chemical-specific parameters for PBPK modeling. 
Parameters 
Contaminants 
Chloroform
(a) TCE
(a) PERC
(a) 
Molecular weight (g/mol) 
Transfer efficiency in the shower stall 
Absorption constants 
Oral (min
−1/kg
−0.25) 
Dermal (cm/min) 
Urinary excretion constant of TCA (min
−1/kg
−0.25) 
Partition coefficients 
Blood:air 
Liver:air 
Fat:air 
Highly perfused tissues:air 
Rest of the body:air 
Skin:air 
Kidney:air 
Water:air 
Placenta:blood 
Metabolic constants 
Maximal rate (µg/min/kg
0.75) 
Vmaxc proportionality constant kidney/liver 
Michaelis-Menten (µg/L) 
Fraction of metabolism in TCA 
Volume of distribution of TCA
119.38 
0.534 
 
0.032 
0.00267 
- 
 
7.43 
17 
280 
17 
12 
12 
11 
3.66 
2.2 
 
211.33 
0.033 
448 
 
- 
131.2 
0.61 
 
0.1667 
0.002 
0.0012 
 
9.2 
62.56 
671.6 
62.56 
21.16 
20.26 
- 
0.83 
2.7 
 
166.67 
- 
1500 
0.25 
0.1  BW 
165.8 
0.66 
 
0.00216 
0.00207 
0.0012 
 
11.58 
61.14 
1449.8 
58.7 
70.6 
275.2 
58.7 
0.79
 
3.2 
 
4 
0.1 
7700 
0.6 
0.1  BW 
REFERENCES [9,35-38] 
[9,36,37, 
39-43] 
[11,36,37, 
39-41,44-46] 
Notes: (a) See Valcke and Krishnan [21] for details. Abbreviations: PERC = tetrachloroethylene;   
TCA = trichloroacetic acid; TCE = trichloroethylene. 
 
The multi-route scenario considered includes daily ingestion of drinking water (separated into five 
episodes spaced by a timelag of three hours) as well as inhalation of vapors in the bathroom and 
dermal contact with water during a once-daily 30 min bathroom exposure, as per the risk assessment of 
Health Canada [14,15]. The water-to-air transfer model used in the present study [47], described 
previously by Haddad et al. [9], does not differentiate the bathroom exposure to chemicals during 
shower from the bath. As the dermal contact and inhalation exposures are described based on the total 
volume of water used, the modeling results described here can be applied to both shower and bath. To 
calculate the air concentration of DWC in the shower stall, a water flow rate of 8.7 L/min [11] (rather 
than 10 L/min [47]), was used as this modification resulted in predicted air concentrations that were 
somewhat closer to the measured data of Jo et al. [3] (not shown).  
The dermal surface to be in contact with water during the shower was considered to be 75% [48].  
A 15 µg/L water concentration was retained since it would yield a daily dose of approximately   
1 µg/kg/day for a 70 kg adult as per the risk assessment of Health Canada [14,15]. The computed DM 
included the total absorbed dose (Dabs), the 24-h area under the arterial blood concentration versus Int. J. Environ. Res. Public Health 2010, 7          
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time curve for either the parent compound (AUCpc) or stable metabolite TCA (AUCmet, for TCE and 
PERC), and the amount metabolized per 24 h per L of liver (Amet).  
2.3. Calculation of LEQ Values 
The LEQ values were calculated based on each DM. Thus, the LEQ value based on Dabs was 
calculated as: 
[DW]  
  Dabs
    LEQ
 
(2) 
where Dabs is the daily absorbed dose in µg/kg BW, and [DW] is the concentration in drinking water 
(i.e., 15 µg/L), and LEQ is expressed in L/kg. For the calculation of the LEQ on the basis of internal 
DM (i.e., AUCpc, AUCmet or Amet), the ratio of the internal DM for the multi-route exposure scenario 
(IDMM-R) and the internal DM for the ingestion exposure only (IDMIng) was multiplied by the 
subpopulation-specific body-weight adjusted drinking water ingestion rate (IngR, in L/kg BW). It 
resulted in subpopulation- and DM-specific LEQ values, expressed in BW-adjusted values (L/kg BW): 
lngR  
IDM
  IDM
    LEQ
Ing
R - M
IDM  
 
(3) 
The BW-adjusted LEQ value was then used to calculate the absolute LEQ value (in L) for 
individuals of a given BW in each subpopulation. 
2.4. Probabilistic Modeling of Internal Dose Metrics for Multi-Route Exposure 
For each subpopulation, MC simulations were performed using Crystal Ball software (Oracle™, 
Redwood Shores, CA) in order to generate statistical distributions of internal DM after 2000 iterations. 
To avoid unrealistic combinations, BW and BH were correlated to 60% based on population 
distribution of body mass index in Canada [49]. The resulting DM distributions allowed the evaluation 
of the variability in internal DM (and corresponding LEQ) for the multi-route exposure scenario. As a 
measure of this variability, a “variability index” was computed as the ratio between the 95th percentile 
and (1) the median of DM in each subpopulation (“VIspop”) and (2) the median in adults (“VI”), for 
each contaminant investigated. This approach is similar to the approach of WHO on human kinetic 
adjustment factor (HKAF) [17,50]. 
2.5. Sensitivity Analyses 
Sensitivity analyses on the model’s input parameters were performed to evaluate to what extent the 
different assumptions made with regard to these parameters affect the outcome of the model. Based on 
the impact on AUCpc, the sensitivity index (SI) for a given parameter (P) was calculated as: 
i PC
i
i
i PC PC
AUC
P
P P
AUC AUC
SI
_ 10
_ 10 _ 


   (4) 
where subscript 10 denotes the AUCpc and parameter (P) value when the latter is reduced by 10% 
compared to the initial value, indicated by subscript i. The greater the resulting SI value, the more Int. J. Environ. Res. Public Health 2010, 7          
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influential is the parameter on AUCpc, while positive and negative SI values are linked to an increase 
and a decrease in AUCpc, respectively, when the parameter is increased. 
3. Results  
3.1. Simulation of Internal Dosimetry for Multi-Route Exposure 
The simulations of multi-route exposure shown in Figure 1 indicate that the neonates would have 
the highest blood concentration of parent compound as well as the fastest decline post-exposure.  
Figure 1. Model simulations of the arterial blood concentration of chloroform (a), TCE (b) 
and PERC (c) during multi-route exposure in an average adult, neonate, child and pregnant 
woman (as per Table 1). The elderly are omitted since their profile is almost 
indistinguishable from an average adult’s. The scenario involves a 30 min bathroom 
exposure at t = 1 hr along with five episodes of drinking water ingestion at t = 2, 5, 8, 11 
and 14 h. 
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Figure 1. Cont. 
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Children would have the second highest blood concentration of the parent compound, while adults 
and PW would have comparable profiles for chloroform and TCE. Blood concentration of PERC in 
PW appears constantly lower than that of adults. The contribution of the exposure resulting from the 
shower is always significant but more so for PERC as the ingestion episodes do not contribute 
significantly to increased blood levels likely because of its low Ko value. Conversely, absorption of 
chloroform and TCE during ingestion is fast, especially for the latter. With regard to TCA (Figure 2), 
blood concentrations resulting from the exposure to TCE (a) and PERC (b) are clearly greater in 
respectively the neonate and child than in the other individuals.  
Figure 2. Model simulations of the blood concentration of TCA as a metabolite of TCE (a) 
and PERC (b) during multi-route exposure in average adult, neonate, child, elderly and 
pregnant woman (as per Table 1). The scenario involves a 30 min bathroom exposure 
along with five episodes of drinking water ingestion at t = 2, 5, 8, 11 and 14 h. 
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Figure 2. Cont. 
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The model results also indicate that elderly would have higher blood levels of TCA than adults and 
even higher than PW. The contribution of TCE exposure via the shower to blood levels of TCA 
appears similar to the contribution of the ingestion events and is proportionally more important in the 
case of TCA produced by the metabolism of PERC. 
The results of sensitivity analyses are presented in Figure 3. They clearly show that considering 
every subpopulation and chemical under study, the most influential parameters of the PBPK models on 
the AUCpc following a multi-route exposure are liver volume and blood flow (for highly metabolized 
chemicals only), fat volume and blood flow (for PERC) and cardiac output and alveolar ventilation 
rate for all chemicals and subpopulations. Intrinsic clearance (=Vmax/Km) is influential for 
chloroform and TCE, but not for PERC. Although the magnitude of the sensitivity indices varies 
between the subpopulations for a given parameter, the absolute trend is generally constant. Exceptions 
are cardiac output (Qc) and alveolar ventilation rates (Qp) in the neonate model for TCE and PERC, as 
well as for the child in the PERC model only, for which a negative sensitivity index indicates that, 
contrary to the other subpopulations/chemicals, AUCpc decreases when the parameter value increases.  Int. J. Environ. Res. Public Health 2010, 7          
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Figure 3. Sensitivity of parent compound’s area under the arterial blood concentration 
versus time (AUC, µg/L  hs) to the physiological parameters of the PBPK models for 
chloroform (a), TCE (b) and PERC (c) in each subpopulation evaluated for a multi-route 
exposure to water contaminated with 15 µg/L. The sensitivity ratios were calculated as the 
change in AUCpc for a 10% decrease in the value of input parameters (Clint, intrinsic 
clearance; Qp, alveolar ventilation rate; Qc, cardiac output; Qx, tissue blood flow and Vx 
tissue volume (l, liver; f, fat; r, rest of the body; sk, skin; k, kidney; h, highly perfused)), 
for a given age, body weight, body height and hepatic content of CYP2E1. In pregnant 
women, the volume of highly perfused tissues includes the feto-placental unit. 
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3.2. Variability of Internal Dosimetry for Multi-Route Exposure 
Table 3 shows the variability of internal DM in each subpopulation for the multi-route exposure. 
None of the VI, calculated as the ratio of the 95th percentile value of DM in a given subpopulation to Int. J. Environ. Res. Public Health 2010, 7          
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the median in adults, exceeds the default value of 3.16 used in risk assessment [51]. The intra-group 
variability (as measured by VIspop) in subpopulations other than adults is almost always lower than the 
inter-group variability (as measured by VI). The exceptions were: neonates on the basis of AUCmet for 
PERC, PW based on AUCmet for TCE and PERC, and Amet for PERC only. Overall, the greater  
inter-subpopulation variability based on AUCpc and AUCmet is observed when the neonates are 
accounted for (VI in the range of 2.07–3.12 (AUCpc) and 2.30–2.52 (AUCmet)), and when the children 
are considered (range: 1.94–2.29) with regard to Amet. 
Table 3. PDF for internal dose metrics and resulting variability indices (VI) obtained for 
multi-route exposure scenario in each subgroup. 
Contaminant 
 
Subpopulation 
Chloroform Trichloroethylene Tetrachloroethylene 
24-h  
AUCpc  
24-h  
Amet 
24-h 
AUCpc  
24-h 
AUCmet 
24-h  
Amet 
24-h 
AUCpc  
24-h 
AUCmet  
24-h  
Amet 
Adults 
Median 
95th percentile  
VI and VIspop 
Neonates 
Median 
95th percentile  
VIspop 
VI  
Children 
Median 
95th percentile  
VIspop 
VI  
Elderly 
Median 
95th percentile  
VIspop 
VI  
Pregnant women 
Median 
95th percentile  
VIspop 
VI  
 
16.4 
21.3 
1.30 
 
32.5 
47.2 
1.45 
2.89 
 
23.6 
28.3 
1.20 
1.73 
 
16.4 
21.4 
1.30 
1.31 
 
17.4 
21.9 
1.26 
1.34 
 
22.5 
27.4 
1.22 
 
31.6 
39.9 
1.26 
1.78 
 
37.9 
46.1 
1.22 
2.05 
 
23.6 
28.0 
1.19 
1.28 
 
26.5 
32.9 
1.24 
1.47 
 
25.4 
36.1 
1.37 
 
58.4 
79.2 
1.36 
3.12 
 
39.9 
49.2 
1.23 
1.94 
 
26.2 
35.6 
1.36 
1.40 
 
26.8 
35.4 
1.32 
1.39 
 
1104 
1346 
1.22 
 
1726 
2539 
1.47 
2.30 
 
1566 
1866 
1.19 
1.68 
 
1222 
1493 
1.22 
1.35 
 
976 
1181 
1.21 
1.07 
 
20.3 
25.5 
1.26 
 
22.1 
32.7 
1.48 
1.61 
 
32.4 
39.4 
1.22 
1.94 
 
21.3 
27.1 
1.27 
1.33 
 
23.4 
29.9 
1.28 
1.48 
 
50.2 
66.8 
1.33 
 
97.3 
103.8 
1.07 
2.07 
 
81.2 
92.1 
1.13 
1.83 
 
51.2 
67.5 
1.32 
1.34 
 
48.6 
60.2 
1.24 
1.20 
 
41.3 
89.9 
2.18 
 
34.4 
103.9 
3.02 
2.52 
 
50.5 
89.9 
1.78 
2.18 
 
45.8 
96.2 
2.10 
2.33 
 
32.8 
68.3 
2.08 
1.66 
 
0.35 
0.76 
2.17 
 
0.20 
0.57 
1.25 
1.63 
 
0.46 
0.80 
1.74 
2.29 
 
0.36 
0.75 
2.08 
2.14 
 
0.34 
0.72 
2.12 
2.06 
Notes: Underlined values denote subgroup with the highest VI for corresponding internal dose surrogate. Italic 
denotes VIs that are greater than the range defined by the corresponding HKAFs obtained by Valcke and 
Krishnan [21] for each exposure routes taken separately. Abbreviations: Amet = amount metabolized for   
24 hours and normalized to liver volume (µg/24 h.L of liver); AUC = area under the arterial blood concentration 
versus time curve (µg.24 h/L); met = circulating metabolite; pc = parent compound;   
spop = subpopulation; VI = variability index as the ratio of the 95th percentile on the median in adult (VI) or in 
subpopulation (VIspop).  
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3.3. Variability in the LEQ Values 
3.3.1. LEQ Based on Absorbed Dose 
Table 4 shows the distribution of the LEQ value in each subpopulation according to the absorbed 
dose of each contaminant under study during the multi-route exposure. In adults, elderly and PW, the 
inhalation route contributes the most to the absorbed dose of chloroform and TCE, followed by DW 
ingestion and dermal contact. This is also true in neonates and children for PERC, but not for 
chloroform and TCE, for which ingestion and inhalation's ranks are inverted. For the multi-route 
exposure, mean BW-adjusted LEQ values are greater in neonates regardless of the contaminant 
considered (0.129–0.134 L/kg BW), as compared to any other subpopulation. In terms of absolute 
values however, the highest LEQs are computed for PW (4.1–5.6 L). Overall, mean LEQ values for the 
multi-route scenario are greater for chloroform (4.1 L in a 70 kg adult), followed closely by TCE  
(4.0 L) and further by PERC (3.6 L). The absolute LEQ values obtained using the 95th percentile value 
of BW-adjusted LEQ do not increase tremendously, given the relatively low intra-group variability in 
absorbed dose. 
Table 4. Variability of chemical-specific LEQ in each subpopulation based on the 
absorbed dose for the multi-route exposure scenario. 
 
LEQ distributions (L/kg BW) 
Contaminant 
Exposure route 
Subpopulation 
Adults 
(70 kg) 
Neonates 
(4 kg) 
Children 
(10 kg) 
Elderly 
(70 kg) 
Pregnant women 
(82.5 kg) 
(b) 
Chloroform 
Inhalation (mean, CV) 
Dermal (mean, CV) 
Ingestion (mean, CV) 
Multi-route (MR) (mean, CV) 
MR LEQ for BW (mean, 95th perc.)
(a) 
Trichloroethylene 
Inhalation (mean, CV) 
Dermal (mean, CV) 
Ingestion (mean, CV) 
Multi-route (MR) (mean, CV) 
MR LEQ for BW (mean, 95th perc.)
(a) 
Tetrachloroethylene 
Inhalation (mean, CV) 
Dermal (mean, CV) 
Ingestion (mean, CV) 
Multi-route (MR) (mean, CV) 
MR LEQ for BW (mean, 95th perc.)
(a) 
 
0.023, 21%
0.015, 13%
0.020, 22%
0.058, 19%
4.06, 5.48 
 
0.027, 21%
0.011, 13%
0.020, 22%
0.058, 20%
4.04, 5.49 
 
0.030, 22%
0.012, 14%
0.010, 21%
0.051, 18%
3.60, 4.69 
 
0.045, 25%
0.039, 21%
0.050, 28%
0.134, 24%
0.54, 0.78 
 
0.052, 25%
0.029, 18%
0.053, 25%
0.134, 24%
0.54, 0.79 
 
0.058, 23%
0.029, 22%
0.042, 23%
0.129, 22%
0.52, 0.74 
 
0.035, 18%
0.027, 12%
0.048, 17%
0.110, 15%
1.10, 1.37 
 
0.040, 18%
0.020, 12%
0.047, 17%
0.107, 15%
1.07, 1.36 
 
0.044, 18%
0.021, 12%
0.033, 15%
0.098, 14%
0.98, 1.21 
 
0.023, 21% 
0.015, 13% 
0.022, 21% 
0.061, 18% 
4.25, 5.64 
 
0.027, 21.0% 
0.011, 12% 
0.022, 21.0% 
0.060, 19% 
4.23, 5.75 
 
0.030, 21% 
0.012, 13% 
0.011, 17% 
0.053, 18% 
3.70, 4.90 
 
0.028, 23% 
0.013, 12% 
0.022, 21% 
0.063, 19% 
5.16, 6.91 
 
0.032, 24% 
0.010, 11% 
0.025, 19% 
0.067, 19% 
5.56, 7.00 
 
0.036, 23% 
0,011, 12% 
0.010, 19% 
0.057, 19% 
4.71, 6.35 
Notes: (a) obtained by multiplying the BW-adjusted LEQ value by the indicated BW. (b) Pregnant women's BW 
is based on the mean BW for an adult women as per the P
3M database to which the mean increase in BW during 
pregnancy (as per ICRP [31]) was added. Abbreviations: BW = body weight; CV = coefficient of variation; 
LEQ = litre-equivalent; MR = multi-route; MR LEQ = multi-route litre-equivalent. Int. J. Environ. Res. Public Health 2010, 7          
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3.3.2. LEQ Based on Internal Dose Metrics 
Table 5 shows the distribution of the LEQ values in each subpopulation according to internal DMs 
of each contaminant under study during the multi-route exposure. Inhalation contributes the most to 
the AUCpc-based LEQ in every subpopulation, followed by dermal exposure except in neonates for 
TCE and in children for TCE and PERC. Ingestion contributes the most to metabolite-based LEQs for 
chloroform and TCE, whereas inhalation route contributes the most in the case of PERC. The 
contribution of dermal exposure to metabolite-based LEQs is always the lowest, except for PERC in 
adults, PW and elderly. Multi-route LEQ values based on AUCpc are always greater in neonates on a 
BW-basis (means of 0.190–0.405 L/kg BW) but are greater in terms of absolute values in PW (means 
of 11.5–28.6 L), followed by adults and the elderly, who share similar values. The same is true on the 
basis of the other DM, with ranges of absolute mean LEQ values for PW and adults of 3.7–6.6 and 
3.0–5.8, respectively, on the basis of Amet and of 4.3–11.9 and 3.5–9.2 based on AUCmet. The 
consideration of the 95th percentile value of BW-adjusted LEQs does not significantly change the 
value observed given a relatively low variability, except in the case of metabolite-based LEQ for 
PERC (Table 5). Actually, PERC exhibits the greatest value of metabolite-based LEQ values (9.2 and 
5.8 in adults on the basis of AUCmet and Amet, respectively) as compared to the other contaminants, 
while LEQ based on AUCpc for chloroform was the highest (mean of 23.5 L in adults, as compared to 
8.8 L and 8.7 L for TCE and PERC, respectively).  
4. Discussion 
The goal of the present work was to evaluate the inter-individual variability of internal dosimetry 
and LEQ values during multi-route exposure to three known DWCs. To do so, the model described 
previously [21] was used given its capability to use age- and gender- specific equations to define 
physiological parameters, thus reflecting the inter-individual variability in the critical determinants of 
toxicokinetics [52,53]. In this regard, the results obtained herein are consistent with the known 
subpopulation-specific differences in these determinants. Indeed, in neonates, greater-than-adult blood 
concentrations of parent compound (and TCA resulting from highly metabolized TCE) is likely 
explained by a greater intake on a BW-basis (Figures 1, 2) [53], whereas children’s greater TCA levels 
from the low (thus enzyme-limited) metabolism of PERC likely result from the age-related differences 
in clearance combined with greater-than-adult intake. In addition, differences in TCA blood levels in 
the elderly and PW as compared to adults are consistent with the respective renal functions in these 
subpopulations [20,26]. Overall, the results taken together suggest that the LEQs on the basis of 
absorbed dose or metabolic dose metrics simulated in this study are comparable to the values used in 
setting the guideline values for these DWCs. Int. J. Environ. Res. Public Health 2010, 7          
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Table 5. Variability of chemical-specific LEQ in each subpopulation based on internal dose metrics for the multi-route exposure scenario. 
Contaminant
Subpopulation                Dose 
metrics 
Exposure route 
LEQ distributions in each subpopulation (L/kg BW)
Chloroform Trichloroethylene Tetrachloroethylene
24-h AUCpc  24-h Amet  24-h AUCpc 24-h  AUCmet  24-h Amet  24-h AUCpc 24-h  AUCmet 24-h  Amet 
Adults (70 kg) 
Inhalation (mean, CV) 
Dermal (mean, CV) 
Ingestion (mean, CV) 
Multi-route (MR), (mean, CV) 
MR LEQ for BW (mean, 95th)
(a) 
Neonates (4 kg) 
Inhalation (mean, CV) 
Dermal (mean, CV) 
Ingestion (mean, CV) 
Multi-route (MR), (mean, CV) 
MR LEQ for BW (mean, 95th)
(a) 
Children (10 kg) 
Inhalation (mean, CV) 
Dermal (mean, CV) 
Ingestion (mean, CV) 
Multi-route (MR), (mean, CV) 
MR LEQ for BW (mean, 95th)
(a) 
Elderly (70 kg) 
Inhalation (mean, CV) 
Dermal (mean, CV) 
Ingestion (mean, CV) 
Multi-route (MR), (mean, CV) 
MR LEQ for BW (mean, 95th)
(a) 
Pregnant women (82.5 kg) 
Inhalation (mean, CV) 
Dermal (mean, CV) 
Ingestion (mean, CV) 
Multi-route (MR), (mean, CV) 
MR LEQ for BW (mean, 95th)
(a) 
 
0.200, 16% 
0.113, 18% 
0.022, 55% 
0.335, 16% 
23.5, 29.9 
 
0.192, 16% 
0.138, 17% 
0.075, 55% 
0.405, 22% 
1.6, 2.3 
 
0.270, 12% 
0.176, 13% 
0.056, 34% 
0.500, 12% 
5.0, 6.0 
 
0.202, 15% 
0.114, 18% 
0.025, 48% 
0.339, 16% 
23.7, 30.7 
 
0.227, 14% 
0.098, 18% 
0.024, 46% 
0.347, 14% 
28.6, 35.8
0.016, 22% 
0.009, 15% 
0.020, 24% 
0.045, 19% 
3.2, 4.3 
 
0.028, 29% 
0.020, 30% 
0.048, 31% 
0.096, 28% 
0.4, 0.6 
 
0.022, 10% 
0.015, 13% 
0.047, 17% 
0.084, 16% 
0.8, 1.1 
 
0.016, 21% 
0.009, 16% 
0.023, 20% 
0.048, 19% 
3.4, 4.5 
 
0.018, 24% 
0.008, 15% 
0.021, 23% 
0.046, 20% 
3.8, 5.3
0.076, 17% 
0.029, 20% 
0.020, 40% 
0.125, 18% 
8.8, 11.6 
 
0.100, 14% 
0.049, 18% 
0.063, 32% 
0.212, 19% 
0.9, 1.1 
 
0.106, 11% 
0.049, 14% 
0.054, 24% 
0.209, 12% 
2.1, 2.5 
 
0.077, 17% 
0.029, 20% 
0.023, 35% 
0.129, 18% 
9.0, 11.9 
 
0.090, 14% 
0.026, 20% 
0.023, 34% 
0.139, 16% 
11.5, 14.5
0.023, 17% 
0.009, 18% 
0.018, 13% 
0.050, 13% 
3.5, 4.3 
 
0.040, 33% 
0.020, 35% 
0.044, 32% 
0.104, 32% 
0.4, 0.6 
 
0.031, 16% 
0.014, 16% 
0.044, 10% 
0.089, 11% 
0.9, 1.1 
 
0.023, 17% 
0.009, 18% 
0.021, 11% 
0.053, 13% 
3.7, 4.5 
 
0.024, 18% 
0.007, 19% 
0.021, 13% 
0.052, 14% 
4.3, 5.2 
0.017, 22% 
0.007, 18% 
0.020, 25% 
0.043, 21% 
3.0, 4.2 
 
0.031, 39% 
0.015, 40% 
0.046, 41% 
0.092, 39% 
0.4, 0.6 
 
0.025, 18% 
0.011, 16% 
0.045, 19% 
0.081, 16% 
0.8, 1.1 
 
0.018, 21% 
0.007, 18% 
0.021, 24% 
0.045, 20% 
3.2, 4.3 
 
0.019, 25% 
0.005, 19% 
0.021, 24% 
0.045, 22% 
3.7, 5.3
0.078, 39% 
0.028, 21% 
0.019, 15% 
0.124, 19% 
8.7, 11.4 
 
0.094, 2% 
0.044, 14% 
0.052, 10% 
0.190, 4% 
0.8, 0.8 
 
0.085, 8% 
0.037, 14% 
0.046, 9% 
0.167, 8% 
1.7, 1.9 
 
0.077, 16% 
0.028, 21% 
0.021, 13% 
0.126, 16% 
8.8, 11.3 
 
0.097, 12% 
0.027, 20% 
0.022, 11% 
0.146, 12% 
12.1, 14.6
0.084, 50% 
0.028, 46% 
0.020, 46% 
0.132, 49% 
9.2, 17.8 
 
0.096, 66% 
0.043, 67% 
0.043, 70% 
0.182, 66% 
0.7, 1.7 
 
0.079, 35% 
0.033, 39% 
0.043, 34% 
0.155, 36% 
1.6, 2.6 
 
0.088, 48% 
0.028, 48% 
0.023, 44% 
0.138, 47% 
9.7, 18.8 
 
0.095, 45% 
0.025, 48% 
0.024, 42% 
0.144. 44% 
11.9, 22.0
 
0.048, 100% 
0.017, 47% 
0.020, 50% 
0.082, 47% 
5.8, 6.3 
 
0.054, 69% 
0.026, 69% 
0.042, 71% 
0.122, 70% 
0.5, 1.2 
 
0.046, 37% 
0.020, 37% 
0.043, 35% 
0.110, 36% 
1.1, 1.8 
 
0.047, 47% 
0.017, 47% 
0.021, 50% 
0.085, 48% 
6.0, 11.6 
 
0.053, 49% 
0.015, 47% 
0.023, 48% 
0.091, 46% 
6.6, 12.3 
Notes: (a) obtained by multiplying the BW-adjusted LEQ value by the indicated BW. Abbreviations: Amet, amount metabolized during 24 hours normalized to liver 
volume (µg/24 h.L of liver); AUC, area under the arterial blood concentration vs time curve (µg.24 h/L); BW, body weight; CV, coefficient of variation; met, 
circulating metabolite; pc, parent compound; LEQ, litre-equivalent; MR, multi-route; MR LEQ, multi-route litre-equivalent. Int. J. Environ. Res. Public Health 2010, 7          
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Current results are also consistent with the premise that the variability of internal dosimetry during 
multi-route exposure is within the range of the variability measures obtained for each route taken 
separately. Indeed, the VI values reported in Table 3 are generally within the range of the route-
specific human kinetic adjustment factors (HKAF) obtained in previous work [21]. The exceptions are 
VI obtained in children on the basis of Amet of chloroform (2.05 versus range of 1.1–1.8) and TCE 
(1.94 versus range of 1.1–1.8), as well as in neonates on the basis of AUCpc of TCE (3.12 versus range 
of 2.2–3.1). Presumably, this is due to the significantly greater water ingestion rate, on a BW basis, in 
neonates and children as compared to adults, which was not typically accounted for by the HKAF for 
oral exposure [21]. When the hepatic metabolism overcomes the increased intake, as occurs in 
children, it results in a greater amount of parent compound being metabolized and a corresponding 
Amet-based VI. The VI for adults exceeding the HKAF range in the previous work based on AUCmet 
for PERC (2.18 versus range of 2.0–2.1) is likely the result of inherent variations from one MC 
simulation to another. Overall and regardless of the DM considered, the intra-subpopulation variability 
appeared rather low, as shown by the various CV obtained for LEQ values (Tables 4–5). Exceptions 
were with the metabolite-based DM of PERC (Table 5). Presumably, this exception is due to the low 
levels of metabolite generated by the biotransformation of PERC, which makes them more sensitive to 
any variation in the determinants of metabolism kinetics. 
The results of the current study with regard to the LEQ value obtained in an average 70 kg adult 
based on the absorbed dose corresponds very well with the values obtained in other studies. In 
particular, the mean LEQ values for multi-route exposure to chloroform (4.1 L) and TCE (4.0 L) are 
identical to the values obtained by Krishnan and Carrier [18], which were retained by Health   
Canada [14,15] in its determination of DWG for these contaminants. They are also comparable to the 
values obtained by Haddad et al. [9] for a 30 min shower, i.e., 4.65 and 4.54 L for chloroform and 
TCE, respectively. The inhalation of vapors during showering contributed to 1.71 and 1.95 L for 
chloroform and TCE respectively, while corresponding numbers in this study are 1.61 and 1.89 L. 
Dermal contact during showering with water containing chloroform and TCE was reported to contribute 
1.44 and 1.08 LEQ in Haddad et al. [9] compared to 1.05 and 0.77 LEQ in the present study. 
Based on internal dose, the results obtained also correspond well to the values of Haddad et al. [9], 
as the mean multi-route LEQ values based on AUCpc were 23.5 and 8.8 L for chloroform and TCE in 
the current study, as compared to 24.0 and 8.5 L. Based on Amet, the corresponding values were 3.2 
and 3.0 L as compared to Haddad et al.'s 3.69 and 3.57 L [9]. No LEQ values were calculated for 
PERC by Rao and Brown [11], but the maximum blood concentration at the end of the 30 min 
exposure to water containing 1 mg/L of PERC via the dermal and inhalation routes only (11–13 µg/L) 
corresponds roughly to the two-thirds of the maximum venous blood concentration obtained in this 
study with the adult model (18 µg/L), for corresponding exposure (not shown).  
Differences in dose-metrics and chemical-specific LEQ values can be explained based on 
toxicokinetic mechanisms. Indeed, greater LEQ based on AUCpc than on the absorbed dose can be 
explained by the fact that during inhalation and dermal exposure, chemicals are not subject to the 
hepatic first pass effect, as opposed to when entering the body through ingested water. Thus, a greater 
dose reaches bloodstream and AUCpc-based LEQ increases correspondingly (Table 5). This difference 
is not accounted for when considering only the absorbed dose to establish LEQ. The effect is stronger Int. J. Environ. Res. Public Health 2010, 7          
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for chloroform than TCE, as chloroform is more extensively metabolized and presents a slower oral 
absorption rate (Ko) such that the hepatic metabolic capacity is not overwhelmed.  
The effect of the first-pass metabolism on the LEQ depends upon the dose metric chosen for the 
assessment. Since a greater amount of parent compound is subject to metabolism during ingestion than 
when inhaled or absorbed by dermal contact, multi-route LEQ values are likely to be smaller when 
based on the amount metabolized than on the absorbed dose. This reasoning is however conditional to 
quick oral absorption. Otherwise, such as for PERC, the LEQ values based on metabolite-based DM 
depends of the hepatic metabolism that occurs because of the income of parent compound in the blood 
via the hepatic artery from the systemic circulation rather than from the gut content via the portal vein. 
As a result, the metabolite-based LEQs are greater than those based solely on the absorbed doses 
(Table 5), due to higher amounts of parent compound being metabolized during inhalation and   
dermal exposure.  
The toxic moiety on which the LEQ values are based needs to be assessed appropriately, should the 
results be used for regulatory purposes. Thus, even though high LEQ values were obtained in the 
present study on the basis of AUCpc, the adverse effects underlying the VTR of these chemicals are 
attributed to the metabolite DM [38,43,47,54], for which LEQ values were lower than the values 
considered by the regulatory agencies [13-16]. Also, the data, and time span covered by the respective 
age range, for each subpopulation, have to be considered in relation to the duration for which the 
guidelines are aimed to provide coverage [55]. 
Several sources of uncertainties are associated with the present study. First, bathroom exposure 
duration (30 min) appears to be a major one since it directly impacts the total dose absorbed, but this 
assumption errs on the side of greater LEQ values and safety due to greater contributions by dermal 
and inhalation routes. Second, the Ko values were extrapolated from animal data for chloroform and 
PERC and this is a fundamental issue since it strongly influences the internal dose metrics for 
ingestion and thus the LEQ values. There might also be some uncertainty relating to the use of the 
same value for partition coefficients (PC) in the PBPK models for all subpopulations despite the fact 
that tissue composition varies somewhat with age and physiological state [20,52,53]. However, the 
data from Mahle et al. [56] have suggested that PC values do not vary significantly with age. Third, 
the results of the sensitivity analyses presented also pointed out that several physiological determinants 
also impact the toxicokinetics and internal dosimetry during multi-route exposure. Focusing to get 
better estimates of these parameters would translate into corresponding certainty in the results obtained 
herein, in particular for highly sensitive parameters, for which the impact varied as a function of the 
chemical and subpopulation considered. For example, a negative sensitivity index for Qp in enzyme-
impaired neonates for poorly metabolized PERC is due to the main contribution of pulmonary 
clearance to overall systemic clearance whereas for highly metabolized chloroform, blood-flow limited 
hepatic clearance is the main contributor to total systemic clearance. As a result, Qp rather contributes 
to the intake of chloroform, as shown by a positive sensitivity index, in the same way as it does for 
each chemical in adults. Fourth and finally, variability in BW-adjusted water intake was not accounted 
for in the MC simulations, but this variability is likely to be more reflective of differences in personal 
habits and environmental conditions rather than variability in the physiological and metabolic 
capacities among people. Future work integrating probabilistic models of human activity pattern, 
environmental distribution and phamacokinetics might facilitate the simulation of LEQ distributions Int. J. Environ. Res. Public Health 2010, 7          
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associated with various multi-route exposure scenarios in subpopulations of interest. However, 
advanced statistical tools and algorithms for interpreting and dissecting the contributions of the various 
sources of variability should be in place to facilitate a meaningful interpretation of the MC simulations 
of LEQ distributions. 
5. Conclusions  
This study has for the first time systematically examined the variability of DM for DWCs during 
multi-route exposure in various subpopulations. It has also confirmed that the LEQ values determined 
based on these DM vary significantly. These considerations should be accounted for in future works 
regarding the determination of drinking water guidelines for contaminants that present a significant 
potential for multi-route exposure.  
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